Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion type Assertion NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_head.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion description "[Gefitinib, an EGFR-tyrosine kinase inhibitor, significantly improve prognosis in patients with advanced non-small cell lung cancer (NSCLC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_provenance.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion evidence source_evidence_literature NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_provenance.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion SIO_000772 25410981 NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_provenance.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion wasDerivedFrom befree-2016 NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_provenance.
- NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_assertion wasGeneratedBy ECO_0000203 NP1238741.RAjrruMCNDh0BEF-oftWaGeyOM7YCszwqw1kPt8nz3Czw130_provenance.